Pharma News

Keep updating your pharma knowledge
22 Jul 2018

DRL launches generic Nexium 24HR capsules in US market

Posted By

Dr Reddy’s Laboratories Ltd. announced the launch of the US Food and Drug Administration (FDA) approved esomeprazole magnesium delayed-release capsules USP, 20 mg, an over-the-counter (OTC) therapeutic equivalent generic version of Nexium 24HR capsules in the United States market.

Esomeprazole magnesium delayed-release capsules USP, 20 mg, is an OTC proton pump inhibitor used to treat frequent heartburn occurring two or more days a week in adults.

The combined market of Nexium 24HR capsules and private label OTC esomeprazole magnesium products had US sales of approximately $311 million for the most recent twelve months ending in May 2018 according to IRI.

Dr. Reddy’s esomeprazole magnesium delayed-release capsules USP, 20 mg is available in 14 count bottles sold in cartons of 1, 2, or 3 bottles each. Each bottle contains a complete 14-day course of treatment. Use only as directed.

Nexium is a registered trademark of AstraZeneca AB.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!